IndiaOne Finance - Company Dashboard

Governance Classic Home

Solara Active Pharma Sciences LtdPharmaceuticalsINE624Z01016Consolidated₹740.80+0.10 (+0.01%)Jun-26

Valuation

Market Cap₹3.58K Cr

TTM PE-1196.85x

Forward PE319.85x

PEG18.97

Book Value₹259.69

P/B2.86x

TTM EPS₹-0.62

Fwd EPS₹2.32

TTM Revenue₹1.43K Cr

TTM PAT₹-1.62 Cr

TTM EBITDA₹191.70 Cr

TTM EBIT₹88.89 Cr

Last Qtr PAT₹16.31 Cr

Last Qtr EBITDA₹61.97 Cr

Last Qtr EBIT₹35.26 Cr

Profitability

ROE-0.13%

ROCE5.59%

TTM NPM-0.11%

TTM EBITDA %13.39%

Curr OPM4.24%

Last OPM2.45%

Curr NPM—

Last NPM—

Curr EPS₹3.52

Last EPS₹2.20

Balance sheet

Equity₹44.51 Cr

Reserve₹1.21K Cr

Total Debt₹683.75 Cr

D/E0.55x

Interest %132.68%

Curr Interest₹21.64 Cr

Price / range

Close₹742.05

vs 52W High—

vs 52W Low—

MA50—

MA200—

Returns

1D+0.05%

1W-1.10%

1M+35.29%

3M+30.43%

6M+65.65%

1Y+8.19%

2Y+0.43%

3Y+105.81%

5Y-55.11%

Diwali+31.76%

Sector peers — Pharmaceuticals

Company	Close	Mkt Cap	TTM P/E	ROE
SUNPHARMA	1837.30	₹4.41L Cr	36.45	14.50%
DIVISLAB	9375.00	₹2.49L Cr	85.06	17.45%
TORNTPHARM	4840.00	₹1.84L Cr	77.32	25.70%
ZYDUSLIFE	1160.00	₹1.16L Cr	25.85	16.94%
CIPLA	1394.50	₹1.13L Cr	33.41	9.75%
LAURUSLABS	1954.00	₹1.06L Cr	96.45	20.58%
AUROPHARMA	1734.00	₹99.77K Cr	27.09	9.79%
DRREDDY	1185.00	₹98.91K Cr	30.63	8.40%

Financial Results

Quarterly and yearly P&L · YoY % on Revenue, Total Income, Expenditure, EBITDA, EBIT, PBT, Net Profit and EPS

Metric	Jun-26	Mar-26	Dec-25	Sep-25	Jun-25	FY25-26
Revenue	381.60+19.6%	387.29	349	313.54	319.15	1,368.98
Other Income	1.92	4.42	0	0.49	0.98	5.89
Total Income	383.52+19.8%	391.71	349	314.03	320.13	1,374.87
Interest	20.23	27.06	22.45	20.83	23.90	94.24
Expenditure	-366.53-18.4%	-382.84	-359.67	-324.11	-309.60	-1,376.22
PBDT	0	0	0	0	0	0
EBITDA	62.01+8.7%	57.55	37.35	34.75	57.03	186.68
Depreciation	-26.71	-26.04	-25.57	-24.49	-23.58	-99.68
EBIT	35.30+5.5%	31.51	11.78	10.26	33.45	87
PBT	16.99+61.3%	9.73	-17.42	-10.08	10.53	-7.24
Tax	0	0	0	0	0	0
Equity	48.06	44.51	0	0	44.34	44.51
OPM	4.43	2.48	-4.99	-3.21	3.29	-0.53
Net Profit	16.99+61.3%	9.73	-17.42	-10.08	10.53	-7.24
NPM	4.43	2.48	-4.99	-3.21	3.29	-0.53
EPS	3.67+49.2%	2.23	-3.97	-2.36	2.46	0

Yearly results

Last 6 financial years · YoY % vs previous FY

Metric	FY 25-26	FY 24-25	FY 23-24	FY 22-23	FY 21-22	FY 20-21
Revenue	1,368.98+6.6%	1,283.76-0.4%	1,288.92-10.7%	1,443.81+13.8%	1,268.34-21.6%	1,616.88
Other Income	5.89	9.14	5.37	22.14	18.76	28.41
Total Income	1,374.87+6.3%	1,292.90-0.1%	1,294.29-11.7%	1,465.95+13.9%	1,287.10-21.8%	1,645.29
Expenditure	-1,376.22-6.4%	-1,293.98+18.8%	-1,592.99-5.4%	-1,510.73-9.8%	-1,375.27+3.4%	-1,424.33
Interest	-94.24	-114.81	-105.97	-90.06	-75.27	-84.47
PBDT	0	0	0	0	0	0
EBITDA	186.68-8.4%	203.84+314.4%	-95.07-170.9%	134.04+66.8%	80.35-79.1%	385.33
Depreciation	-99.68	-99.25	-103.03	-110.90	-112.01	-108.31
EBIT	87-16.8%	104.59+152.8%	-198.10-956.1%	23.14+173.1%	-31.66-111.4%	277.02
PBT	-7.24-570.4%	-1.08+99.8%	-488.34-990.5%	-44.78+51.1%	-91.66-141.5%	220.96
Tax	0	0	-78.54	22.57	33.10	0
Equity	44.51	40.25	0	0	0	0
OPM (%)	-0.53	-0.08	-38.00	-3.00	-7.00	13.00
Net Profit	-7.24-570.4%	-1.08+99.8%	-566.88-2452.4%	-22.21+62.1%	-58.56-126.5%	220.96
NPM (%)	-0.53	-0.08	-44.00	-2.00	-5.00	13.00
EPS (Rs)	0	0+100.0%	-157.48-2452.4%	-6.17+62.1%	-16.29-123.7%	68.86
CEPS	0	0	-157.48	-6.17	-16.29	64.40

Metric	Jun-26	Mar-26	Dec-25	Sep-25	Jun-25	FY25-26
Revenue	381.60+19.6%	387.29	349	313.54	319.15	1,368.98
Other Income	2.69	4.69	0	0.49	0.98	6.16
Total Income	384.29+20.0%	391.98	349	314.03	320.13	1,375.14
Interest	21.64	27.57	22.45	20.83	23.90	94.75
Expenditure	-367.98-18.9%	-383.24	-359.68	-324.13	-309.61	-1,376.66
PBDT	0	0	0	0	0	0
EBITDA	61.97+8.7%	57.66	37.34	34.73	57.02	186.75
Depreciation	-26.71	-26.04	-25.57	-24.49	-23.58	-99.68
EBIT	35.26+5.4%	31.62	11.77	10.24	33.44	87.07
PBT	16.31+55.0%	9.60	0	-10.10	10.52	-7.41
Tax	0	0	0	0	0	0
Equity	48.06	44.51	0	44.47	44.34	44.51
OPM	4.24	2.45	0.00	-3.22	3.29	-0.54
Net Profit	16.31+55.0%	9.60	-17.43	-10.10	10.52	-7.41
NPM	4.24	2.45	-4.99	-3.22	3.29	-0.54
EPS	3.52+43.1%	2.20	-3.98	-2.36	2.46	0

Yearly results

Last 6 financial years · YoY % vs previous FY

Metric	FY 25-26	FY 24-25	FY 23-24	FY 22-23	FY 21-22	FY 20-21
Revenue	1,368.98+6.6%	1,283.76-0.4%	1,288.92-10.7%	1,443.81+13.8%	1,268.34-21.6%	1,616.88
Other Income	6.16	8.32	5.37	22.55	20.02	28.77
Total Income	1,375.14+6.4%	1,292.08-0.2%	1,294.29-11.7%	1,466.36+13.8%	1,288.36-21.7%	1,645.65
Expenditure	-1,376.66-6.6%	-1,291.54+18.9%	-1,592.54-5.4%	-1,511.17-9.8%	-1,375.97+3.4%	-1,424.15
Interest	-94.75	-114.81	-105.11	-90.06	-75.28	-84.48
PBDT	0	0	0	0	0	0
EBITDA	186.75-9.5%	206.28+316.7%	-95.18-171.1%	133.89+67.4%	79.97-79.3%	385.87
Depreciation	-99.68	-99.25	-103.33	-111.19	-112.32	-108.66
EBIT	87.07-18.6%	107.03+153.9%	-198.51-974.5%	22.70+170.2%	-32.35-111.7%	277.21
PBT	-7.41-1472.2%	0.54+100.1%	-488.42-990.0%	-44.81+50.8%	-91.10-141.1%	221.50
Tax	0	0	-78.54	22.57	32.81	-0.15
Equity	44.51	40.25	0	0	0	0
OPM (%)	-0.54	0.04	-37.74	-3.06	-7.07	13.46
Net Profit	-7.41-1472.2%	0.54+100.1%	-566.96-2449.3%	-22.24+61.8%	-58.29-126.3%	221.35
NPM (%)	-0.54	0.04	-43.80	-1.52	-4.52	13.45
EPS (Rs)	0-100.0%	0.14+100.1%	-157.62-2458.8%	-6.16+61.9%	-16.18-123.4%	69
CEPS	0	0.14	-157.62	-6.16	-16.18	64.52

Corporate Actions

Dividends, bonus issues, and stock splits

Dividend

Year	Type	Amount	Ex-Date
2021	Final Dividend	3	18 Aug 2021
2021	Interim Dividend	4	19 Nov 2020
2020	Final Dividend	2	28 Jul 2020
2019	Final Dividend	5	06 Aug 2019

Bonus

No bonus history.

Split

No split history.

Financial Results

Standalone

Yearly results

Yearly

Consolidated

Yearly results

Yearly

Corporate Actions

Dividend

Bonus

Split